Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?
(2023) In Nature Reviews Rheumatology 19(10). p.675-675
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/6378d1a1-9732-4f71-b816-f36e0f32111b
- author
- Andréasson, Kristofer LU ; Hamberg, Viggo ; Wigén, Jenny LU and Westergren-Thorsson, Gunilla LU
- organization
- publishing date
- 2023-08-21
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nature Reviews Rheumatology
- volume
- 19
- issue
- 10
- pages
- 675 - 675
- publisher
- Nature Publishing Group
- external identifiers
-
- scopus:85168454359
- pmid:37605003
- ISSN
- 1759-4804
- DOI
- 10.1038/s41584-023-01013-4
- language
- English
- LU publication?
- yes
- id
- 6378d1a1-9732-4f71-b816-f36e0f32111b
- date added to LUP
- 2023-08-25 14:40:31
- date last changed
- 2024-04-20 01:59:10
@article{6378d1a1-9732-4f71-b816-f36e0f32111b,
author = {{Andréasson, Kristofer and Hamberg, Viggo and Wigén, Jenny and Westergren-Thorsson, Gunilla}},
issn = {{1759-4804}},
language = {{eng}},
month = {{08}},
number = {{10}},
pages = {{675--675}},
publisher = {{Nature Publishing Group}},
series = {{Nature Reviews Rheumatology}},
title = {{Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?}},
url = {{http://dx.doi.org/10.1038/s41584-023-01013-4}},
doi = {{10.1038/s41584-023-01013-4}},
volume = {{19}},
year = {{2023}},
}